BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9177146)

  • 1. Cancer biology in ulcerative colitis and potential use in endoscopic surveillance.
    Shapiro BD; Lashner BA
    Gastrointest Endosc Clin N Am; 1997 Jul; 7(3):453-68. PubMed ID: 9177146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
    Brüwer M; Schmid KW; Senninger N; Schürmann G
    World J Surg; 2002 Mar; 26(3):390-6. PubMed ID: 11865380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal p53 immunohistochemistry is associated with an increased colorectal cancer-related mortality in patients with ulcerative colitis.
    Lashner BA; Bauer WM; Rybicki LA; Goldblum JR
    Am J Gastroenterol; 2003 Jun; 98(6):1423-7. PubMed ID: 12818291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer surveillance in ulcerative colitis.
    Chambers WM; Warren BF; Jewell DP; Mortensen NJ
    Br J Surg; 2005 Aug; 92(8):928-36. PubMed ID: 16034807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
    Fujii S; Fujimori T; Chiba T
    J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis.
    Lashner BA; Shapiro BD; Husain A; Goldblum JR
    Am J Gastroenterol; 1999 Feb; 94(2):456-62. PubMed ID: 10022646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
    Kukitsu T; Takayama T; Miyanishi K; Nobuoka A; Katsuki S; Sato Y; Takimoto R; Matsunaga T; Kato J; Sonoda T; Sakamaki S; Niitsu Y
    Clin Cancer Res; 2008 Jan; 14(1):48-54. PubMed ID: 18172251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high degree of aneuploidy, loss of p53 gene, and low soluble p53 protein serum levels are detected in ulcerative colitis patients.
    Rosman-Urbach M; Niv Y; Birk Y; Smirnoff P; Zusman I; Morgenstern S; Schwartz B
    Dis Colon Rectum; 2004 Mar; 47(3):304-13. PubMed ID: 14991492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Premalignant and malignant changes in idiopathic inflammatory bowel disease].
    Knezević-Usaj S; Panisić M; Tarabar D; Cuk V; Brajuković G; Petrović M
    Acta Chir Iugosl; 2000; 47(1-2):43-50. PubMed ID: 10953365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitis.
    Lindberg JO; Stenling RB; Rutegård JN
    Br J Surg; 1999 Jul; 86(7):947-50. PubMed ID: 10417571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Colon cancer associated with ulcerative colitis and early diagnosis].
    Tsujikawa T; Bamba T
    Nihon Rinsho; 1999 Nov; 57(11):2608-13. PubMed ID: 10572440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis.
    Azarschab P; Porschen R; Gregor M; Blin N; Holzmann K
    Genes Chromosomes Cancer; 2002 Oct; 35(2):121-6. PubMed ID: 12203775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis.
    Markowitz J; McKinley M; Kahn E; Stiel L; Rosa J; Grancher K; Daum F
    Am J Gastroenterol; 1997 Nov; 92(11):2001-6. PubMed ID: 9362180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
    Sjöqvist U; Tribukait B; Ost A; Einarsson C; Oxelmark L; Löfberg R
    Anticancer Res; 2004; 24(5B):3121-7. PubMed ID: 15510599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.
    Lang SM; Heinzlmann M; Stratakis DF; Teschauer W; Loeschke K
    Am J Gastroenterol; 1997 Dec; 92(12):2166-70. PubMed ID: 9399746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling dysplasia detection in ulcerative colitis: clinical implications of surveillance intensity.
    Awais D; Siegel CA; Higgins PD
    Gut; 2009 Nov; 58(11):1498-503. PubMed ID: 19651634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of patients with chronic ulcerative colitis. WHO Collaborating Centre for the Prevention of Colorectal Cancer.
    Levin B; Lennard-Jones J; Riddell RH; Sachar D; Winawer SJ
    Bull World Health Organ; 1991; 69(1):121-6. PubMed ID: 1905205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer surveillance colonoscopy in ulcerative colitis: sense or nonsense?
    Schapiro M
    Schweiz Med Wochenschr Suppl; 1996; 79():5S-8S. PubMed ID: 8701261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.